ITC Ltd
NSE: ITC BSE: 500875FMCG
Established in 1910, ITC is the largest cigarette manufacturer and seller in the country. ITC operates in four business segments at present — FMCG Cigarettes, FMCG Others, Paperboards, Paper and Packaging, and Agri Business. [1]
₹309
52W: ₹287 — ₹444
PE 19.2 · Book ₹54.7 · +465% vs bookMarket Cap₹3,87,348 Cr
Stock P/E19.2Price to Earnings
ROCE36.9%Return on Capital
ROE27.9%Return on Equity
Div. Yield4.66%Face Value ₹1
Strengths
- +Company has reduced debt.
- +Company is almost debt free.
- +Stock is providing a good dividend yield of 4.59%.
- +Company has a good return on equity (ROE) track record: 3 Years ROE 28.4%
- +Company has been maintaining a healthy dividend payout of 79.3%
Weaknesses
- −The company has delivered a poor sales growth of 8.73% over past five years.
- −Earnings include an other income of Rs.17,929 Cr.
Shareholding Pattern
Promoters0%
FIIs34.83%
DIIs49.15%
Public15.96%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| FIIs | 40.47% | 40.53%▲0.1 | 40.17%▼0.4 | 39.87%▼0.3 | 37.98%▼1.9 | 37.39%▼0.6 | 36.11%▼1.3 | 34.83%▼1.3 |
| DIIs | 44.02% | 44.59%▲0.6 | 44.91%▲0.3 | 45.19%▲0.3 | 46.91%▲1.7 | 47.41%▲0.5 | 48.9%▲1.5 | 49.15%▲0.3 |
| Public | 15.47% | 14.83%▼0.6 | 14.88%▲0.1 | 14.9%▲0.0 | 15.07%▲0.2 | 15.16%▲0.1 | 14.95%▼0.2 | 15.96%▲1.0 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 16,550 | 15,696 | 15,734 | 16,373 | 18,649 | 17,053 | 17,248 | 19,750 | 18,021 | 18,017 |
| Expenses | 10,508 | 9,956 | 9,892 | 10,287 | 12,526 | 11,224 | 11,262 | 13,489 | 11,769 | 11,746 |
| Operating Profit | 6,042 | 5,739 | 5,842 | 6,087 | 6,123 | 5,828 | 5,986 | 6,261 | 6,252 | 6,271 |
| OPM % | 37% | 37% | 37% | 37% | 33% | 34% | 35% | 32% | 35% | 35% |
| Net Profit | 4,927 | 5,572 | 5,020 | 4,917 | 5,078 | 5,638 | 19,562 | 4,912 | 5,180 | 5,089 |
| EPS ₹ | 3.95 | 4.47 | 4.02 | 3.94 | 4.06 | 4.51 | 15.63 | 3.92 | 4.13 | 4.06 |
AI Insights
Revenue Trend
TTM revenue at ₹73,037Cr, up 5.4% YoY. OPM at 34%.
Debt Position
Borrowings at ₹143Cr. Debt-to-equity ratio: 0.00x. Healthy balance sheet.
Capex Cycle
CWIP at ₹1,268Cr (6% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 49.15% (+7.23pp change). FIIs: 34.83% (-8.79pp change). Promoters hold 0%.
Margin & Efficiency
ROCE declining from 51% (Mar 2014) to 37% (Mar 2025). Working capital days: 43.
Valuation
PE 19.2x with 36.9% ROCE. Price is 465% above book value of ₹54.7. Dividend yield: 4.66%.
Recent Announcements
- Compliances-Reg.24(A)-Annual Secretarial Compliance 1d - ITC filed its FY2025-26 annual secretarial compliance report; auditor reported full compliance and no additional non-compliances.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 12 May - Publication of Notice re: Transfer of unclaimed Dividend and Ordinary Shares to the Investor Education and Protection Fund
- Board Meeting Intimation for Board Meeting - 21St May, 2026 7 May
- Amalgamation Of Sresta Natural Bioproducts Private Limited And Wimco Limited With The Company 7 May - NCLT sanctioned Sresta and Wimco amalgamation with ITC; effective 1 June 2026.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Apr - Publication of Advertisement re: Loss of Share Certificates
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse